MUKKA
Mukka Proteins Limited
Each stock's 10,000-path forecast, rendered as light.
Mukka Proteins Limited (MUKKA) Stock Analysis & Case Study
Is MUKKA a good buy? The data-driven verdict.
Mukka Proteins Limited (MUKKA) trades at ₹23,on the numbers it worth a closer look, a Downstox Snapshot Score of 57/100.
On the numbers, Mukka Proteins Limited (MUKKA) worth a closer look, a Downstox Snapshot Score of 57/100, weighing inexpensive at 13.5× earnings, ROE of 11.1%, a 54% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
MUKKA fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How MUKKA ranks against the 2,373 companies in our screener
- MUKKA's market cap of 702 Cr ranks in the 33rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- MUKKA's book value of ₹17 ranks in the 16th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- MUKKA's promoter holding of 73.3% ranks in the 83rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- MUKKA's 3-year profit (PAT) growth of 6.0% ranks in the 37th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- MUKKA's 3-year revenue growth of 7.0% ranks in the 41st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- MUKKA's debt-to-equity ratio of 1.56x is lower than 8% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is MUKKA overvalued? MUKKA P/E vs peers
MUKKA trades at 13.5× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
MUKKA share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.4y of MUKKA history (-25%/yr drift, 36%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| MUKKA 2027 | ₹15 | ₹24 | ₹38 | +4% |
| MUKKA 2028 | ₹13 | ₹25 | ₹48 | +7% |
| MUKKA 2029 | ₹12 | ₹26 | ₹57 | +11% |
| MUKKA 2030 | ₹11 | ₹27 | ₹67 | +15% |
| MUKKA 2031 | ₹10 | ₹28 | ₹77 | +19% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability MUKKA goes up, or doubles?
The bull case for MUKKA
- MUKKA's P/E of 13.5x is lower than 78% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Low price-to-book of 1.41×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹57.
The bear case & risks
- MUKKA's return on equity of 11.1% ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹12.
MUKKA volatility & expected range, how bumpy is the ride?
Over the last 2.4 years MUKKA compounded at -25%/year with annualized volatility of 36%. That volatility implies a 1-year 80% range of ₹15-₹38, the honest backbone behind any single price target.
MUKKA price forecast, the full 60-month probability fan
MUKKA price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds MUKKA hits common targets within the simulated horizon?
Full multi-horizon detail on the MUKKA price target & forecast page.
MUKKA Piotroski F-Score: 4/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. MUKKA scores 4/8, mixed financial health.
MUKKA MTF margin & leverage across 4 brokers
Margin Trading Facility lets you buy MUKKA with part of the capital. Lower margin % = higher leverage. Rates compared across 4 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Dhan | 50.00% | 2.0× |
| Kotak Neo | 100.00% | 1.0× |
| Anand RathiCHEAPEST | 31.88% | 3.1× |
| Share India | 32.00% | 3.1× |
Compare every broker on the MUKKA MTF page.
About Mukka Proteins Limited: sector, index & market-cap context
Mukka Proteins Limited (MUKKA) is a small-cap NSE-listed company, with a market capitalisation of ₹702 Cr. See more stocks on our screener.
How the MUKKA Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Mukka Proteins Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
MUKKA analysis, FAQs
Is Mukka Proteins Limited (MUKKA) a good buy?
On the numbers, Mukka Proteins Limited (MUKKA) worth a closer look, a Downstox Snapshot Score of 57/100, weighing inexpensive at 13.5× earnings, ROE of 11.1%, a 54% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is MUKKA overvalued or undervalued?
MUKKA trades at 13.5× earnings, inexpensive versus the ~22× long-run Nifty average.
What is the MUKKA share price target for 2031?
MUKKA's probability-weighted 2031 median target is ₹28, with an 80% range of ₹10-₹77 (10,000-path Monte-Carlo).
What is the probability MUKKA doubles in 5 years?
The modelled probability of MUKKA reaching ₹47 (2×) within 5 years is 26%.
What is the bull case for MUKKA?
MUKKA's P/E of 13.5x is lower than 78% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. Low price-to-book of 1.41×, the market is paying little over the company's net assets.
What are the risks in MUKKA?
MUKKA's return on equity of 11.1% ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.